News
President Trump signs executive order aimed at forcing drug companies to lower costs
SAN ANTONIO — Today, President Trump signed an executive order aiming to cut prescription drug prices for Medicare. The order is already getting big-time push back from pharmaceutical companies, which says this could result in drug shortages.
Pharmaceutical tariffs could increase drug prices and drug shortages, negatively impacting the health care system, experts warn.
(Reuters) -A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight ...
Observers warn of the negative health consequences if US President Donald Trump follows through on his promise to impose tariffs on pharmaceuticals. Susan Jaffe reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback